Breaking News Instant updates and real-time market news.

TRIL

Trillium Therapeutics

$6.20

0.05 (0.81%)

18:32
06/19/18
06/19
18:32
06/19/18
18:32

Trillium Therapeutics announces 'at-the-market' issuance program

Trillium Therapeutics announced that it has entered into a sales agreement with Cowen and Company pursuant to which the company may, at its discretion and from time to time during the term of the Sales Agreement, sell, through the Agent, acting as agent and/or principal, such number of common shares of the Company as would result in aggregate gross proceeds to the Company of up to $25M. Sales of Common Shares through the Agent, acting as agent, will be made through "at the market" issuances on the Nasdaq Capital Market at the market price prevailing at the time of each sale, and, as a result, sale prices may vary. No Common Shares will be offered or sold on the Toronto Stock Exchange or any other trading markets in Canada.

TRIL Trillium Therapeutics
$6.20

0.05 (0.81%)

07/17/17
HCWC
07/17/17
INITIATION
Target $7
HCWC
Buy
Trillium Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis started Trillium Therapeutics with a Buy rating and $7 price target. The analyst estimates that Trillium's lead product, TTI-621, which is currently being evaluated in Phase 1 and Phase 1b clinical studies, could be the first marketed CD47-targeting therapy and can generate peak sales of C$1.4B for hematologic and solid tumors.
12/14/17
HCWC
12/14/17
NO CHANGE
Target $10
HCWC
Buy
Trillium price target raised to $10 from $7 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth raised his price target for Trillium Therapeutics to $10 saying the company presented "impressive" first results from the Phase 1 study of intratumoral TTI-621 for the treatment of relapsed or refractory mycosis fungoides. The analyst believes TTI-621 could become a "highly efficacious treatment." He reiterates a Buy rating on the shares.
04/13/18
LEER
04/13/18
INITIATION
Target $7
LEER
Market Perform
Trillium Therapeutics resumed with a Market Perform at Leerink
Leerink analyst Jonathan Chan resumed coverage of Trillium Therapeutics with a Market Perform rating and $7 price target. The analyst views the early-stage CD47 space as "competitive with an increasing number of programs in development." he finds it difficult to pick a winner at this time.

TODAY'S FREE FLY STORIES

14:30
07/20/18
07/20
14:30
07/20/18
14:30
General news
More dollar index slippage and yield rises »

More dollar index…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

14:24
07/20/18
07/20
14:24
07/20/18
14:24
Hot Stocks
Sen. Schumer: Trump's backtrack on ZTE example of 'being weak' »

Top Senate Democrat Chuck…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

ZTCOY

ZTE Corp.

$0.00

(0.00%)

14:21
07/20/18
07/20
14:21
07/20/18
14:21
Periodicals
Lawmakers remove anti-ZTE measure from defense bill, Reuters says »

Top Senate Democrat Chuck…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
07/20/18
07/20
14:17
07/20/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
07/20/18
07/20
14:16
07/20/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RS

Reliance Steel

$91.30

0.24 (0.26%)

14:10
07/20/18
07/20
14:10
07/20/18
14:10
Options
Call buyers in Reliant Steel ahead of earnings next week »

Call buyers in Reliant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$280.04

0.09 (0.03%)

14:08
07/20/18
07/20
14:08
07/20/18
14:08
General news
Trump worried Fed will hike rates twice this year, CNBC reports 

Reference Link

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$280.04

0.09 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
07/20/18
07/20
14:05
07/20/18
14:05
General news
Action Economics Survey results: »

Action Economics Survey…

SWN

Southwestern Energy

$5.36

-0.005 (-0.09%)

13:55
07/20/18
07/20
13:55
07/20/18
13:55
Options
Southwestern Energy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

13:55
07/20/18
07/20
13:55
07/20/18
13:55
General news
Treasury Curve Action: longer yields led to steepening »

Treasury Curve Action:…

LHO

LaSalle Hotel

$35.10

0.11 (0.31%)

, PEB

Pebblebrook Hotel

$39.66

-0.06 (-0.15%)

13:47
07/20/18
07/20
13:47
07/20/18
13:47
Hot Stocks
LaSalle Hotel confirms receipt of letter from Pebblebrook Hotel »

LaSalle Hotel Properties…

LHO

LaSalle Hotel

$35.10

0.11 (0.31%)

PEB

Pebblebrook Hotel

$39.66

-0.06 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ARDX

Ardelyx

$4.40

-0.05 (-1.12%)

13:42
07/20/18
07/20
13:42
07/20/18
13:42
Hot Stocks
Breaking Hot Stocks news story on Ardelyx »

Adage Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LITE

Lumentum

$55.30

-4.1 (-6.90%)

13:42
07/20/18
07/20
13:42
07/20/18
13:42
Recommendations
Lumentum analyst commentary  »

Lumentum should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$64.01

-0.49 (-0.76%)

13:40
07/20/18
07/20
13:40
07/20/18
13:40
Options
Hess sees aggressive call buying ahead of earnings next week »

Hess sees aggressive call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

FFIV

F5 Networks

$172.71

1.06 (0.62%)

, S

Sprint

$5.46

-0.015 (-0.27%)

13:39
07/20/18
07/20
13:39
07/20/18
13:39
Hot Stocks
F5 Networks names Sprint CEO Michel Combes to board »

F5 Networks (FFIV)…

FFIV

F5 Networks

$172.71

1.06 (0.62%)

S

Sprint

$5.46

-0.015 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 08

    Aug

  • 09

    Aug

LGF.A

Lionsgate

$24.92

-0.04 (-0.16%)

, LGF.B

Lionsgate

$23.91

-0.06 (-0.25%)

13:37
07/20/18
07/20
13:37
07/20/18
13:37
Periodicals
Ex-Lions Gate general counsel was mired in legal drama prior to exit, WSJ says »

Lions Gate general…

LGF.A

Lionsgate

$24.92

-0.04 (-0.16%)

LGF.B

Lionsgate

$23.91

-0.06 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

UNIT

Uniti Group

$17.85

-0.785 (-4.21%)

13:35
07/20/18
07/20
13:35
07/20/18
13:35
Options
Uniti Group put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

LITE

Lumentum

$55.30

-4.1 (-6.90%)

13:33
07/20/18
07/20
13:33
07/20/18
13:33
Recommendations
Lumentum analyst commentary  »

Lumentum selloff today a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$280.19

0.24 (0.09%)

, IWM

iShares Trust Russell 2000 Index Fund

$169.13

-0.01 (-0.01%)

13:30
07/20/18
07/20
13:30
07/20/18
13:30
Technical Analysis
On The Fly: ETF fund flow highlights »

For the past week, there…

SPY

SPDR S&P 500 ETF Trust

$280.19

0.24 (0.09%)

IWM

iShares Trust Russell 2000 Index Fund

$169.13

-0.01 (-0.01%)

QQQ

Invesco QQQ Trust

$179.51

0.48 (0.27%)

BBJP

JPMorgan BetaBuilders Japan ETF

$24.08

0.065 (0.27%)

XLF

Financial Select Sector

$27.59

0.085 (0.31%)

XLI

Industrial Select Sector SPDR

$74.65

0.12 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CP

Canadian Pacific

$194.73

2.71 (1.41%)

13:24
07/20/18
07/20
13:24
07/20/18
13:24
Hot Stocks
Canadian Pacific, TCRC-T&E ratify four-year agreement »

Canadian Pacific Railway…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,821.64

8.79 (0.48%)

13:17
07/20/18
07/20
13:17
07/20/18
13:17
Hot Stocks
Amazon announces new fulfillment center in Spokane »

Amazon.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/20/18
07/20
13:17
07/20/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/20/18
07/20
13:16
07/20/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESL

Esterline

$81.10

5.6 (7.42%)

13:11
07/20/18
07/20
13:11
07/20/18
13:11
Periodicals
Esterline in early stages of exploring sale, WSJ reports »

Esterline Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

SN

Sanchez Energy

$4.72

-0.1 (-2.07%)

13:10
07/20/18
07/20
13:10
07/20/18
13:10
Options
Sizable put spreads in Sanchez Energy as a bullish play is extended »

Sizable put spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.